Cargando…
Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome
Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) coul...
Autores principales: | Otto, Matthias, Krebs, Jörg, Welker, Peter, Holm, René, Thiel, Manfred, Gattinoni, Luciano, Quintel, Michael, Tsagogiorgas, Charalambos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004724/ https://www.ncbi.nlm.nih.gov/pubmed/33806903 http://dx.doi.org/10.3390/pharmaceutics13030431 |
Ejemplares similares
-
Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
por: Tsagogiorgas, Charalambos, et al.
Publicado: (2023) -
The Use of an Inspiration-Synchronized Vibrating Mesh Nebulizer for Prolonged Inhalative Iloprost Administration in Mechanically Ventilated Patients—An In Vitro Model
por: Otto, Matthias, et al.
Publicado: (2023) -
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
por: Steven, Philipp, et al.
Publicado: (2017) -
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study
por: Steven, Philipp, et al.
Publicado: (2015) -
A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis
por: De Majumdar, S., et al.
Publicado: (2017)